Acalabrutinib Plus RICE Followed By Autologous Hematopoietic Cell Transplantation and/or Acalabrutinib Maintenance Therapy for Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma

被引：1
|
作者：
Bailey, Neil
Tsomo, Tenzin
Szeto, Jennie
Bensinger, William I.
Egan, Daniel
Hegerova, Livia
Mawad, Raya
Batchelder, Ami
Fesler, Joanna
Holdread, Heather
Glennie, Sonia
Hall, Judson
Ferry, Joey
Bailey, Megumi
Kane, David
Pagel, John M.
Patel, Krish
机构：
来源：
BLOOD | 2020年 / 136卷
关键词：
D O I：
10.1182/blood-2020-141074
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Outcomes of Autologous Hematopoietic Cell Transplantation in Diffuse Large B Cell Lymphoma Refractory to Firstline Chemoimmunotherapy
    Bal, Susan
    Costa, Luciano J.
    Sauter, Craig
    Litovich, Carlos
    Hamadani, Mehdi
    TRANSPLANTATION AND CELLULAR THERAPY, 2021, 27 (01):
  • [32] Zanubrutinib Plus Salvage Chemotherapy in Refractory/Relapsed Diffuse Large B-Cell Lymphoma Patients Non-Candidate for Autologous Stem Cell Transplantation: A Retrospective Study
    He, Sha
    Sun, Jie
    Zhong, Dani
    Rong, Chao
    Liao, Chengcheng
    Tan, Xiaohong
    BLOOD, 2023, 142
  • [33] Phase I Study of Acalabrutinib Plus Danvatirsen (AZD9150) in Relapsed/Refractory Diffuse Large B-Cell Lymphoma Including Circulating Tumor DNA Biomarker Assessment
    Roschewski, Mark
    Patel, Manish R.
    Reagan, Patrick M.
    Saba, Nakhle S.
    Collins, Graham P.
    Arkenau, Hendrik-Tobias
    de Vos, Sven
    Nuttall, Barrett
    Acar, Melih
    Burke, Kathleen
    White, Rafael D.
    Udriste, Maria
    Sharma, Shringi
    Dougherty, Brian
    Stetson, Daniel
    Jenkins, David
    Mortlock, Andrew
    Forcina, Alessandra
    Munugalavadla, Veerendra
    Flinn, Ian
    CLINICAL CANCER RESEARCH, 2023, 29 (17) : 3301 - 3312
  • [34] Magrolimab plus rituximab with or without chemotherapy in patients with relapsed/refractory diffuse large B-cell lymphoma
    Maakaron, Joseph E.
    Asch, Adam
    Popplewell, Leslie
    Collins, Graham P.
    Flinn, Ian W.
    Ghosh, Nilanjan
    Keane, Colm
    Ku, Matthew
    Mehta, Amitkumar
    Roschewski, Mark
    Hacohen-Kleiman, Gal
    Huo, Yanan
    Zhang, Yi
    Renard, Camille
    Smith, Sonali M.
    Advani, Ranjana
    BLOOD ADVANCES, 2024, 8 (22) : 5864 - 5874
  • [35] Safety and Efficacy of Rituximab Plus Bendamustine in Relapsed or Refractory Diffuse Large B-Cell Lymphoma Patients
    Arcari, Annalisa
    Chiappella, Annalisa
    Valenti, Vanessa
    Zanlari, Luca
    Tani, Monica
    Marasca, Roberto
    Cabras, Maria Giuseppina
    Spina, Michele
    Santagostino, Alberto
    Ilariucci, Fiorella
    Carli, Giuseppe
    Musto, Pellegrino
    Savini, Paolo
    Marino, Dario
    Ghio, Francesco
    Gentile, Massimo
    Cox, Maria Christina
    Della Seta, Roberta
    Vallisa, Daniele
    BLOOD, 2014, 124 (21)
  • [36] Bendamustine plus Rituximab as Treatment for Elderly Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma
    Vacirca, Jeffrey
    Tabbara, Imad
    Acs, Peter
    Shumaker, Grace
    BLOOD, 2010, 116 (21) : 1157 - 1157
  • [37] A phase 2 study of inotuzumab ozogamicin and rituximab, followed by autologous stem cell transplant in patients with relapsed/refractory diffuse large B-cell lymphoma
    Wagner-Johnston, Nina D.
    Goy, Andre
    Rodriguez, Maria A.
    Ehmann, W. Christopher
    Hamlin, Paul A.
    Radford, John
    Thieblemont, Catherine
    Suh, Cheolwon
    Sweetenham, John
    Huang, Yifan
    Sullivan, Sharon T.
    Vandendries, Erik R.
    Gisselbrecht, Christian
    LEUKEMIA & LYMPHOMA, 2015, 56 (10) : 2863 - 2869
  • [38] Role of Consolidative Radiation Therapy Following Autologous Stem Cell Transplant for Relapsed or Refractory Diffuse Large B-Cell Lymphoma
    Coutu, B. G.
    Wilke, C. T.
    Yuan, J.
    Cao, Q.
    Vernon, M. R.
    Lee, C. K.
    Dusenbery, K. E.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 93 (03): : S66 - S66
  • [39] The efficacy and safety of autologous stem cell transplantation in relapsed chemosensitive and chemoresistant patients with diffuse large B-cell lymphoma
    Armatys, A.
    Wieczorkiewicz-Kabut, A.
    Panz-Klapuch, M.
    Koclega, A.
    Kopinska, A. J.
    Kata, D.
    Wozniczka, K.
    Helbig, G.
    NEOPLASMA, 2020, 67 (06) : 1431 - 1436
  • [40] Maintenance therapy in diffuse large B-cell lymphoma
    Michallet, Anne-Sophie
    Lebras, Laure
    Coiffier, Bertrand
    CURRENT OPINION IN ONCOLOGY, 2012, 24 (05) : 461 - 465
12345